Pre‐column Derivatization and Ultra‐High‐Performance Liquid Chromatography‐Tandem Mass Spectrometry‐based Method Development of Gemcitabine in Reversed‐Phase Column for Pharmaceutical Applications

Documenti analoghi

• A Rapid and Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for the Quantification of Nitrosamine Impurities in an Anticoagulant Drug: Application to Drug Substance and Pharmaceutical Dosage Forms
  di: Abhishek Sharma, et al.
  Pubblicazione: (2025)
• Sustainable and Stability Indicating Liquid Chromatography–Mass Spectrometry Method for the Quantitation of Delafloxacin in Pharmaceutical Formulations
  di: Sami Jebali, et al.
  Pubblicazione: (2024)
• Method Development and Validation for the Determination of Belzutifan in Biological Samples by Liquid Chromatography and Tandem Mass Spectrometry
  di: Vasudeva Rao Bobba, et al.
  Pubblicazione: (2025)
• Development and Validation of Trace Level Quantification of Nine Azido Genotoxic Impurities in Losartan Potassium Active Pharmaceutical Ingredients by Liquid Chromatography‐Tandem Mass Spectrometry
  di: Praveen Kumar Kondaveti, et al.
  Pubblicazione: (2024)
• A Liquid Chromatography‐Tandem Mass Spectrometry Bioanalytical Method Development and Validation for the Determination of Pacritinib in Plasma
  di: Mulamraju Aruna Kumar, et al.
  Pubblicazione: (2024)